...
首页> 外文期刊>AJR: American Journal of Roentgenology : Including Diagnostic Radiology, Radiation Oncology, Nuclear Medicine, Ultrasonography and Related Basic Sciences >MRI versus (1)(3)(1)I whole-body scintigraphy for the detection of lymph node recurrences in differentiated thyroid carcinoma.
【24h】

MRI versus (1)(3)(1)I whole-body scintigraphy for the detection of lymph node recurrences in differentiated thyroid carcinoma.

机译:MRI与(1)(3)(1)I全身闪烁显像技术在分化型甲状腺癌的淋巴结复发中的检测。

获取原文
获取原文并翻译 | 示例
           

摘要

OBJECTIVE: The aim of this study was to compare the clinical usefulness of MRI and radioiodine ((1)(3)(1)I) whole-body scintigraphy for the detection of lymph node metastases in differentiated thyroid carcinoma (DTC). MATERIALS AND METHODS: After surgery and (1)(3)(1)I therapy, 40 patients with DTC underwent (1)(3)(1)I whole-body scintigraphy and MRI. Each patient was clinically suspected of having or already had evidence of nodal recurrences (confirmed by laboratory studies, cytologic analysis, or whole-body scintigraphy). Planar whole-body scintigraphy was done after administration of 111 MBq of (1)(3)(1)I, and MRI was done using spin-echo T1- and T2-weighted imaging, T1-weighted spin-echo imaging with fat suppression, and STIR sequences. RESULTS: MRI detected nodal metastases as partly or entirely cystic and as heterogeneously enhanced on contrast-enhanced T1-weighted images. Hyperintense cystic areas appeared on T1- and T2-weighted images and STIR sequences in 57% of cases. Nodal metastases showed extracapsular spread in 24% of patients. MRI results were true-positive in 76%, true-negative in 90%, false-negative in 24%, and false-positive in 11% of cases, whereas (1)(3)(1)I whole-body scintigraphy results were true-positive in 71%, true-negative in 91%, and false-negative in 29% of cases. There were no false-positive results of (1)(3)(1)I whole-body scintigraphy. False-negative whole-body scintigraphy was induced by tumor dedifferentiation. The sensitivity, specificity, accuracy, positive predictive value, and negative predictive value of MRI were 76.2%, 89.5%, 82.5%, 88.9%, and 77.3%, respectively, and the corresponding values for (1)(3)(1)I whole-body scintigraphy were 71.4%, 100%, 85%, 100%, and 76%, respectively. CONCLUSION: Whole-body scintigraphy is more specific than MRI in the detection of nodal metastases in patients with DTC. The principal value of MRI is in non-iodine-avid recurrences and in evaluation of mediastinal foci.
机译:目的:本研究的目的是比较MRI和放射性碘((1)(3)(1)I)全身闪烁显像技术对分化型甲状腺癌(DTC)淋巴结转移的检测的临床价值。材料与方法:手术及(1)(3)(1)I治疗后,对40例DTC患者进行了(1)(3)(1)I全身闪烁显像和MRI检查。每个患者在临床上都被怀疑有或已经有淋巴结复发的证据(通过实验室研究,细胞学分析或全身闪烁扫描证实)。给予(1)(3)(1)I 111 MBq后进行平面全身闪烁显像,并使用自旋回波T1和T2加权成像,T1加权自旋回波成像并抑制脂肪进行MRI和STIR序列。结果:在增强的T1加权图像上,MRI检测到淋巴结转移部分或全部为囊性,并且异质性增强。 57%的病例在T1和T2加权图像和STIR序列上出现高强度囊性区域。淋巴结转移显示囊外扩散在24%的患者中。 MRI结果的阳性率为76%,阴性为90%,假阴性为24%,假阳性为11%,而(1)(3)(1)I全身闪烁显像结果阳性率为71%,真阴性为91%,假阴性为29%。 (1)(3)(1)I全身闪烁显像没有假阳性结果。假阴性全身闪烁显像是由肿瘤去分化引起的。 MRI的敏感性,特异性,准确性,阳性预测值和阴性预测值分别为76.2%,89.5%,82.5%,88.9%和77.3%,以及(1)(3)(1)的相应值我的全身闪烁显像分别为71.4%,100%,85%,100%和76%。结论:全身闪烁显像在DTC患者淋巴结转移的检测中比MRI更具有特异性。 MRI的主要价值在于非碘-avid复发和纵隔灶的评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号